BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7705671)

  • 1. Predicting endometrial cancer among older women who present with abnormal vaginal bleeding.
    Feldman S; Cook EF; Harlow BL; Berkowitz RS
    Gynecol Oncol; 1995 Mar; 56(3):376-81. PubMed ID: 7705671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of patients with recurrent postmenopausal bleeding.
    Twu NF; Chen SS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):628-33. PubMed ID: 10969449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
    Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
    Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy.
    Feldman S; Shapter A; Welch WR; Berkowitz RS
    Gynecol Oncol; 1994 Oct; 55(1):56-9. PubMed ID: 7959267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial biopsy in DUB.
    Ash SJ; Farrell SA; Flowerdew G
    J Reprod Med; 1996 Dec; 41(12):892-6. PubMed ID: 8979202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of strategies to evaluate postmenopausal bleeding.
    Feldman S; Berkowitz RS; Tosteson AN
    Obstet Gynecol; 1993 Jun; 81(6):968-75. PubMed ID: 8497365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of endometrial hyperplasia in renal transplanted women.
    Bobrowska K; Kamiński P; Cyganek A; Pietrzak B; Jabiry-Zieniewicz Z; Durlik M; Paczek L
    Transplant Proc; 2006; 38(1):177-9. PubMed ID: 16504696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pathway for evaluating women with abnormal uterine bleeding.
    Dunn TS; Stamm CA; Delorit M; Goldberg G
    J Reprod Med; 2001 Sep; 46(9):831-4. PubMed ID: 11584486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of hysteroscopy in the diagnosis and follow-up of endometrial hyperplasia].
    Gubbini G; Filoni M; Linsalata I; Stagnozzi R; Stefanetti M; Marabini A
    Minerva Ginecol; 1998 Apr; 50(4):125-33. PubMed ID: 9691636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic evaluation of endouterine manual aspiration for the detection of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding].
    Suarez Rincón AE; Arévalo Lagunas I; Cerpa Batres MG; Díaz Rodríguez MC
    Ginecol Obstet Mex; 2000 Jan; 68():1-6. PubMed ID: 10774094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of endometrial hyperplasia: an evaluation of current practice.
    Clark TJ; Neelakantan D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):259-64. PubMed ID: 16246481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysteroscopy in perimenopausal and postmenopausal women with abnormal uterine bleeding.
    Mencaglia L; Perino A; Hamou J
    J Reprod Med; 1987 Aug; 32(8):577-82. PubMed ID: 3656297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia.
    Espindola D; Kennedy KA; Fischer EG
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):717-37, ix. PubMed ID: 18061866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
    Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
    Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
    J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
    Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
    J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding.
    Weber AM; Belinson JL; Piedmonte MR
    Obstet Gynecol; 1999 Apr; 93(4):594-8. PubMed ID: 10214840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
    Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
    Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance.
    Cheng RF; Hernandez E; Anderson LL; Heller PB; Shank R
    J Reprod Med; 1999 Nov; 44(11):922-8. PubMed ID: 10589401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.